News and Events - Catalent
WEBFeb 2, 2024 · Catalent Appoints David McErlane as Biologics Segment Leader. Sep 18, 2023. Mr. McErlane will lead all of Catalent’s Biologics businesses and global service offerings – including development, drug substance manufacturing, drug product fill-and-finish, cell and gene therapy, and analytical services.
Novo Holdings to Acquire Catalent
WEBFeb 5, 2024 · Catalent and Novo Holdings have entered into a merger agreement in an all-cash transaction that values Catalent at $16.5 billion. Catalent Stockholders to Receive $63.50 Per Share in Cash, Representing a 47.5% Premium to the 60-day Volume-Weighted Average Price as of February 2, 2024
Catalent to Acquire Metrics Contract Services for $475 Million
WEBAug 9, 2022 · Catalent to Acquire Metrics Contract Services for $475 Million to Expand High-Potent Capabilities and Oral Development and Manufacturing Capacity. SOMERSET, N.J. – August 9, 2022 – Catalent, Inc. (NYSE: CTLT), the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, …
Catalent Stockholders Approve Transaction with Novo Holdings
WEBMay 29, 2024 · Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, today announced that, at its Special Meeting of Stockholders (the “Special Meeting”) held earlier today, its stockholders voted to approve the pending transaction under which Novo Holdings A/S …
Catalent Announces Governance Enhancements and New ...
WEBAug 29, 2023 · News Details. View All News. Catalent Announces Governance Enhancements and New Initiatives to Drive Value. August 29, 2023. Adding Four New Independent Directors. Appoints John Greisch as Executive Chair. Establishes New Strategic and Operational Review Committee of the Board.
Novo Nordisk parent to buy Catalent to expand Wegovy supply
WEBNov 21, 2023 · Novo Nordisk's parent company said it will acquire drug manufacturer Catalent in a $16.5 billion deal that could help boost the supply of the highly popular weight loss injection Wegovy and ...
Exclusive: Catalent to explore options after Elliott deal-sources
WEBAug 28, 2023 · Catalent Inc (CTLT.N) is close to reaching a settlement with activist investor Elliott Investment Management which will include new directors and a pledge to review strategic alternatives such as...
Skip to content